FDA authorizes limited prescriptions of Paxlovid by pharmacists

Advertisements

FDA authorizes limited prescriptions of Paxlovid by pharmacists
hnesich_drupal
Jul 6, 2022

The Food and Drug Administration today authorized state-licensed pharmacists to prescribe Paxlovid (nirmatrelvir and ritonavir) to patients as a treatment for those at high risk of severe COVID-19. Because Paxlovid must be taken within five days of symptom onset, the change could spur expanded access and more-timely treatment of eligible patients. The change was made through an amended emergency use authorization. 

Headline
Advertisements
Shopping Cart
Generated by Feedzy
error: Content is protected !!
Share via
Copy link
Powered by Social Snap